Letian Song

Letian SONG is an experienced immunology scientist currently serving as the study director and principal investigator at ITR Laboratories Canada Inc. since January 2023, focusing on method development, validation, and sample analysis under GLP requirements. Previously, from November 2018 to January 2023, Letian worked as a Scientist (II) at Hyasynth Bio, specializing in synthetic biology with an emphasis on protein engineering and metabolic engineering in yeast. Prior roles include Research Associate at Concordia University, where Letian developed industrial strains of Aspergillus niger using CRISPR/Cas9, and Postdoctoral Fellow at Institut national de la recherche scientifique, focusing on protein engineering of CAZy enzymes. Letian also held the position of Associate Scientist at CNRS from 2010 to 2011. Letian earned a Ph.D. in Enzymology and Microbiology from INSA Toulouse and a B.Sc. in Pharmaceutical Sciences from Ocean University of China.